Stories

Researchers at Novartis are combining modern techniques with an old approach to drug discovery and getting surprising results.

Why are some sickle cell disease patients protected from the disease? Learn about our biomedical research in the field.

Novartis supports promising young scientists who want to improve their chances to attain advanced science degrees.

The word “biopsy” typically conjures images of large needles. Lab technicians—and scientists working to discover new medicines—need enough tissue from a patient to prepare and evaluate a sample.

Novartis innovation and events such as mHealth Challenge enable patients to access data and personal information about their health via mobile devices.

Cambridge neighbors, NIBR and Harvard, further disrupt technology. Read how their alliance is accelerating drug discovery.

Novartis researchers use automation to rapidly identify starting points for new drugs.

Novartis is working to tackle the problem of counterfeit drugs, which are a threat to patient health.

University students majoring in the life sciences or business often have trouble imagining the direction of their careers.

Using new technologies, researchers have developed a deeper understanding of how cells function, changing conceptions of disease.

The cause of a rare, inherited, often fatal kidney disease in many patients remained elusive for years, despite multiple attempts to solve the mystery. Then in 2012, a team of researchers cracked some of the unsolved cases in just six weeks.